TrueBeam™ for prostate cancer
The prostate can move during radiation treatment as a result of breathing and normal movement in the intestines. Radiation oncologists typically expand the treatment area to ensure the moving target is irradiated. In the process, healthy tissue near the prostate also may be affected, leading to a high rate of urinary, bowel and sexual side effects.
By targeting cancer cells and avoiding nearby healthy tissues, TrueBeam™ with Calypso beacon tracking spares the bladder, colon and other critical structures. Common side effects of prostate cancer radiation therapy, such as bowel or bladder urgency, or erectile dysfunction, may be reduced through the use of TrueBeam technology.